Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Tempest Therapeutics (NASDAQ:TPST) through any online brokerage.
Other companies in Tempest Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Tempest Therapeutics has a consensus price target of $28.33.
The stock price for Tempest Therapeutics (NASDAQ: TPST) is $0.805 last updated September 22, 2026 at 10:12 AM EDT.
There are no upcoming dividends for Tempest Therapeutics.
Tempest Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Tempest Therapeutics.
Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.